CJC 1295/Ipamorelin 400mcg/400mcg troche

CJC-1295 and Ipamorelin are synthetic peptides classified as growth hormone secretagogues, meaning they stimulate the body’s own production of growth hormone (GH). CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that promotes sustained GH release, while Ipamorelin is a growth hormone-releasing peptide (GHRP) that activates ghrelin receptors to trigger GH pulses with minimal effect on cortisol or prolactin. These two peptides are often combined for their complementary mechanisms of action. The combination is used in wellness and longevity settings to support lean muscle growth, fat metabolism, recovery, and improved sleep quality. By increasing GH and downstream IGF-1 levels, these peptides may contribute to enhanced tissue repair and metabolic function. A troche formulation (dissolvable lozenge) allows for sublingual/oral administration. However, clinical evidence supporting the bioavailability and effectiveness of oral/sublingual peptide delivery is limited compared to injectable forms, and these formulations are typically compounded and used off-label under medical supervision.